512 related articles for article (PubMed ID: 32393653)
21. Export of RNA-derived modified nucleosides by equilibrative nucleoside transporters defines the magnitude of autophagy response and Zika virus replication.
Shi SL; Fukuda H; Chujo T; Kouwaki T; Oshiumi H; Tomizawa K; Wei FY
RNA Biol; 2021 Oct; 18(sup1):478-495. PubMed ID: 34382915
[TBL] [Abstract][Full Text] [Related]
22. S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) is Not a Selective Inhibitor of Equilibrative Nucleoside Transporters but Also Blocks Efflux Activity of Breast Cancer Resistance Protein.
Karbanova S; Sorf A; Jiraskova L; Lalinska A; Ptackova Z; Staud F; Cerveny L
Pharm Res; 2020 Feb; 37(3):58. PubMed ID: 32086630
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of nucleoside uptake by the basolateral side of the sheep choroid plexus epithelium perfused in situ.
Markovic I; Segal M; Djuricic B; Redzic Z
Exp Physiol; 2008 Mar; 93(3):325-33. PubMed ID: 18039975
[TBL] [Abstract][Full Text] [Related]
24. Blood-to-Testis Transport of Ribavirin Involves Carrier-Mediated Processes at the Blood-Testis Barrier.
Ito T; Kubo Y; Tega Y; Akanuma SI; Hosoya KI
J Pharm Sci; 2024 Apr; ():. PubMed ID: 38679231
[TBL] [Abstract][Full Text] [Related]
25. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.
Crawford CR; Patel DH; Naeve C; Belt JA
J Biol Chem; 1998 Feb; 273(9):5288-93. PubMed ID: 9478986
[TBL] [Abstract][Full Text] [Related]
26. Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.
Stolk M; Cooper E; Vilk G; Litchfield DW; Hammond JR
Biochem J; 2005 Mar; 386(Pt 2):281-9. PubMed ID: 15500446
[TBL] [Abstract][Full Text] [Related]
27. Regulation of equilibrative nucleoside uptake by protein kinase inhibitors.
Huang M; Wang Y; Mitchell BS; Graves LM
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1445-50. PubMed ID: 15571274
[TBL] [Abstract][Full Text] [Related]
28. Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine.
Karbanova S; Cerveny L; Ceckova M; Ptackova Z; Jiraskova L; Greenwood S; Staud F
Placenta; 2017 Dec; 60():86-92. PubMed ID: 29208244
[TBL] [Abstract][Full Text] [Related]
29. Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells.
Leung GP; Man RY; Tse CM
Biochem Pharmacol; 2005 Aug; 70(3):355-62. PubMed ID: 15963471
[TBL] [Abstract][Full Text] [Related]
30. Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2.
Shimada T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Shimada T; Sawamoto K; Miyamoto K; Kitagawa H; Ohta T; Tamai I; Sai Y
J Pharm Sci; 2015 Sep; 104(9):3162-9. PubMed ID: 26037416
[TBL] [Abstract][Full Text] [Related]
31. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
Bone DB; Hammond JR
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury.
Eckle T; Hughes K; Ehrentraut H; Brodsky KS; Rosenberger P; Choi DS; Ravid K; Weng T; Xia Y; Blackburn MR; Eltzschig HK
FASEB J; 2013 Aug; 27(8):3078-89. PubMed ID: 23603835
[TBL] [Abstract][Full Text] [Related]
33. Characterization of nucleoside transport systems in cultured rat epididymal epithelium.
Leung GP; Ward JL; Wong PY; Tse CM
Am J Physiol Cell Physiol; 2001 May; 280(5):C1076-82. PubMed ID: 11287319
[TBL] [Abstract][Full Text] [Related]
34. Influx mechanism of 2',3'-dideoxyinosine and uridine at the blood-placenta barrier.
Sato K; Sai Y; Nishimura T; Chishu T; Shimpo S; Kose N; Nakashima E
Placenta; 2009 Mar; 30(3):263-9. PubMed ID: 19135251
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.
Kiss A; Farah K; Kim J; Garriock RJ; Drysdale TA; Hammond JR
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):363-72. PubMed ID: 11085929
[TBL] [Abstract][Full Text] [Related]
36. Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1.
Chishu T; Sai Y; Nishimura T; Sato K; Kose N; Nakashima E
Placenta; 2008 May; 29(5):461-7. PubMed ID: 18329095
[TBL] [Abstract][Full Text] [Related]
37. Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells.
Hioki M; Shimada T; Yuan T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Sawamoto K; Akashita G; Miyamoto KI; Ohta T; Tamai I; Shimada T; Sai Y
Biopharm Drug Dispos; 2018 May; 39(5):256-264. PubMed ID: 29682747
[TBL] [Abstract][Full Text] [Related]
38. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
[TBL] [Abstract][Full Text] [Related]
39. Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.
Li R; Mak WW; Li J; Zheng C; Shiu PH; Seto SW; Lee SM; Leung GP
Front Pharmacol; 2022; 13():837555. PubMed ID: 35264969
[TBL] [Abstract][Full Text] [Related]
40. Contribution of equilibrative nucleoside transporter (ENT) 2 to fluorouracil transport in rat placental trophoblast cells.
Takagi A; Nishimura T; Akashi T; Tomi M; Nakashima E
Drug Metab Pharmacokinet; 2017 Apr; 32(2):151-156. PubMed ID: 28209435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
